It’s no longer Trudeau: Canada’s PM resigns
Economist Podcasts
00:00
Navigating the Challenges of AI in Drug Development
This chapter explores the intricate challenges of drug development, focusing on the role of AI amidst a high failure rate in the industry. While acknowledging the limitations of AI in improving approval rates, there is a sense of optimism for the emergence of AI-inspired drugs by 2025.
Transcript
Play full episode
